Synapse - Alison Moskowitz

Search Within

Alison Moskowitz

Results (354)

Survival for relapsed/refractory Hodgkin lymphoma patients with recurrent or persistent disease following autologous hematopoietic stem cell transplantation treated in the modern era

Meeting Abstract

Rajeeve, S.; Shah, G. L.; Moskowitz, C. H.; Moskowitz, A. J.
Blood (2018)

Fulltext@MSK | Save

Nivolumab combined with brentuximab vedotin for relapsed/refractory primary mediastinal large B-cell lymphoma: Preliminary results from the phase 2 CheckMate 436 trial

Meeting Abstract

Moskowitz, A. J.; Santoro, A.; Gritti, G.; Brice, P.; Cunningham, D.; Barr, P.; Kline, J.; Kuruvilla, J.; Johnson, N. A.; Mehta-Shah, N.; more...
Blood (2018)

Fulltext@MSK | Save

The combination of duvelisib, a PI3K-δ,γ inhibitor, and romidepsin is highly active in relapsed/refractory peripheral T-cell lymphoma with low rates of transaminitis: Results of parallel multicenter, phase 1 combination studies with expansion cohorts

Meeting Abstract

Horwitz, S. M.; Moskowitz, A. J.; Jacobsen, E. D.; Mehta-Shah, N.; Khodadoust, M. S.; Fisher, D. C.; Myskowski, P.; Wang, E. B. K.; Tawa, M.; Davey, T.; more...
Blood (2018)

Fulltext@MSK | Save

Phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory classic Hodgkin lymphoma: Part 3 (concurrent dosing) results and updated progression-free survival results from parts 1 and 2 (staggered dosing)

Meeting Abstract

Advani, R. H.; Moskowitz, A. J.; Bartlett, N. L.; Vose, J. M.; Ramchandren, R.; Feldman, T. A.; LaCasce, A. S.; Christian, B. A.; Ansell, S. M.; Moskowitz, C. H.; more...
Blood (2018)

Fulltext@MSK | Save

Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma

Journal Article

Kumar, A.; Vardhana, S.; Moskowitz, A. J.; Porcu, P.; Dogan, A.; Dubovsky, J. A.; Matasar, M. J.; Zhang, Z.; Younes, A.; Horwitz, S. M.
Blood Advances (2018)

Fulltext@MSK | Save

Durable responses observed with JAK inhibition in T-cell lymphomas

Meeting Abstract

Moskowitz, A. J.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Obadi, O.; Motylinski, K.; Jarjies, C.; Galasso, N.; Hancock, H.; Davey, T.; more...
Blood (2018)

Fulltext@MSK | Save

Initial results of a phase II study of sequential chemotherapy and lenalidomide followed by rituximab and lenalidomide maintenance for untreated mantle cell lymphoma

Meeting Abstract

Kumar, A.; Zelenetz, A. D.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Laraque, L.; more...
Blood (2018)

Fulltext@MSK | Save

Durable responses with pembrolizumab in relapsed/refractory mycosis fungoides and Sezary syndrome: Final results from a phase 2 multicenter study

Meeting Abstract

Khodadoust, M. S.; Rook, A.; Porcu, P.; Foss, F. M.; Moskowitz, A. J.; Shustov, A. R.; Shanbhag, S.; Sokol, L.; Fling, S. P.; Li, S.; more...
Blood (2018)

Fulltext@MSK | Save

Romidepsin activity in T follicular helper(TFH)-phenotype PTCL versus non TFH treated on the same clinical trials

Meeting Abstract

Ghione, P.; Ozkaya, N.; Faruque, P.; Mehta-Shah, N.; Lunning, M. A.; Ruan, J.; Galasso, N.; Moskowitz, A. J.; Dogan, A.; Horwitz, S. M.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma

Meeting Abstract

Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save